| abstract |
Provided herein are Diaminopyrimidine Compounds having the following structures: n n n n n n n n n n n n wherein R 1 , R 2 , R 3 , and R 4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway. |